baber/WOPTO huggingface dataset:
Patent NZ-546844-A (NZ)
Title: High-strength, low-temperature stable herbicidal formulations of 2,4-dichlorophenoxy acetic acid salts
Inventor: LINTON MARK RICHARD
Filed: 2006-04-28
Abstract: A high-strength herbicidal formulation containing high concentrations of 2,4-dichlorophenoxy acetic acid (2,4-D) salt mixtures is disclosed, which comprises a mixture of a dimethylamine (DMA) salt of 2,4-dichlorophenoxy acetic acid (2,4-D) with a dimethylethanolamine (DMEA) salt or a diethylethanolamine (DEEA) salt of 2,4-D or a mixture thereof in a relative ratio of 2,4-D DMA salt to 2,4-D DMEA or DEEA salt of between about 55 : 45 to about 40 : 60, wherein the formulation contains at least about 625 gram acid equivalents per liter (gae/L) to about 740 gae/L based upon the 2,4-D acid equivalent of the 2,4-D salt mixture. This high-strength herbicidal formulation comprising a mixture of 2,4-D salts exhibits significantly greater low temperature stability at high concentrations.
Patent NZ-552249-A (NZ)
Title: Dry-forming three-dimensional wood fiber webs
Inventor: FUJII JOHN S
IPC: B29C43/04
Filed: 2005-06-09
Abstract: The three dimensional mould into which a flat dry-formed mat of wood fibres is deep drawn so as to mould the mat into a three dimensional wood fibre structural core is provided with fillets and curved corners (not illustrated) adjacent the laminating platforms 2, 6 and load bearing diagonal elements 1, 5, 4. This facilitates fibre draw during the moulding process at the intersection of the laminating platforms and load bearing diagonal elements and prevents tearing of the mat.
Patent NZ-553702-A (NZ)
Title: Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
Inventor: ANDERSSON CARL-MAGNUS A
IPC: A61K31/4468
Filed: 2005-09-26
Abstract: Disclosed is crystalline form C of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate that exhibits a X-ray powder diffraction pattern comprising peaks having d-values in angstroms of about 10.7, about 4.84, about 4.57, and about 3.77, said compound is useful in the inhibition of an activity of a monoamine receptor, preferably a serotonin receptor of the 5-HT2A subclass. Also disclosed is a pharmaceutical composition comprising the above crystalline form and a pharmaceutically acceptable carrier or diluent.
Patent NZ-554395-A (NZ)
Title: Method of indicating an assigned elevator to a user by an acoustical tone
Inventor: GERSTENKORN BERNHARD
Filed: 2007-04-10
Abstract: A method of assigning a user to an elevator system with several elevators, in which the user issues a destination call and at least one elevator is determined to serve the destination call, is disclosed. An acoustic signal is announced to the user to designate the elevator. All of the signals that designate the different elevators are exclusively formed by means of one single single-frequency signal tone, and the various signals that identify the individual elevators are distinguishable to the user by a predefined signal duration and/or at least one predefined signal interruption.
Patent NZ-554953-A (NZ)
Title: A lithium battery using iron disulphide with a pH raising additive to raise the mixture to a pH between 4 to 14
Inventor: MARPLE JACK W
IPC: H01M50/463
Filed: 2005-12-16
Abstract: An electrochemical battery cell is disclosed. The battery has a housing which contains a negative electrode comprising lithium, a positive electrode comprising a mixture of iron disulfide and a pH raising additive compound and a non-aqueous electrolyte mixture comprising at least one salt dissolved in a solvent disposed within the housing. The pH raising additive compound is present in an effective amount to provide the electrode mixture with a calculated pH of 4.0 to 14.0 in order to hinder or prevent dendrite formation which might cause an internal short circuit.
Patent NZ-560884-A (NZ)
Title: Components for securing articles
Inventor: BURTON WARREN LESLIE
Filed: 2007-08-23
Abstract: A component for securing an article, wherein the component includes, in cross-section, a substantially straight elongated first portion, one end of which is connected to an end portion which is substantially straight and which extends away from the first portion. The longitudinal axis of the end portion is inclined to the longitudinal axis of the first portion at an obtuse angle. The first portion includes a groove formed at or adjacent the joint between the first portion and the end portion, on the side of the component opposite to the obtuse angle.
Patent NZ-560976-A (NZ)
Title: Biomarkers for ovarian cancer and endometrial cancer: hepcidin
Inventor: FUNG ERIC THOMAS
IPC: A01N37/18
Filed: 2006-03-10
Abstract: Disclosed is a method of determining ovarian cancer status in a subject comprising measuring a hepcidin biomarker wherein an elevated hepcidin level is correlated with ovarian cancer. Other biomarkers that can be measured include transthyretin, Apo A1, transferring, CTAP-III, ITIH4 and beta-2 microglobulin.
Patent NZ-563188-A (NZ)
Title: Power control
Inventor: BOYS JOHN TALBOT
IPC: H02J5/00
Filed: 2007-11-05
Abstract: A pick-up circuit for an inductive power transfer (IPT) system is disclosed. The pick-up circuit comprises a series-tuned pick-up coil and a plurality of parallel AC processing circuits, which are located between the series-tuned pick-up coil and the output. Each processing circuit is adapted to produce an output signal based directly or indirectly on a voltage of the series-tuned pick-up coil, and which comprises a switch for selectively coupling the processing circuit to the output so as to selectively provide the respective output signal to the output of the pick-up circuit.
Patent NZ-564711-A (NZ)
Title: Personnel recruitment with feedback system
Inventor: WAI TONY ANDREW
Filed: 2007-12-20
Abstract: A system for facilitating contract personnel recruitment is disclosed. The system comprises: a database storing records for a plurality of contract personnel; a web interface on a web-portal for allowing contract personnel and businesses to register and for entering and updating the records with contract personnel information; a feedback interface on the web-portal which is automatically triggered by a feedback trigger upon completion of a contract, allowing the business to enter contract personnel performance information, wherein the contract personnel performance information is stored with the records in the database; a search interface on the web-portal allowing a potential business to search for contract personnel by using a plurality of attributes, wherein the search results are affected by the stored contract personnel performance information and a watchlist; and a "terms of contract" template which contains terms of contract information for hiring personnel which will be completed by the business to generate a job contract and then sent to the selected contract personnel for acceptance after the contract personnel had been selected.
Patent NZ-570245-A (NZ)
Title: Template-fixed peptidomimetics with antimicrobial activity
Inventor: GOMBERT FRANK
IPC: A61K38/04
Filed: 2007-01-15
Abstract: Disclosed is a compound of formula (I) wherein the template contains DPro-LPro or LPro-DPro and Z is a chain of 12 alpha-amino acids whereby the amino acids at positions P1 to P12 of the chain are: P1: Ala, Cit, Thr, Asp, Glu; P2: Trp, Tyr; P3: Ile, Cal, Nle, Chg, Cha; P4: Dab, Lys, Gln; P5: Lys, Dab, Orn; P6: Dab, DDab, Lys; P7: His, Lys, Gln, Dab; P8: Tyr, Trp, Ser; P9: Dab, Lys; P10: Dab, Lys; P11: Ala, Abu, Thr, Gly, Pro, Hse, Ile, Nva, DAla, DVal, Aib, Nle, Chg, Cha, Gln, Asp, Glu, Cpa, t-BuG, Leu, Val, Asn; and P12: Dab, Lys, Gln, Ser. The document further discloses uses of said compounds in the manufacture of a medicament for treatment or prevention of infections or related diseases thereof, said compound is further disclosed to be used as a disinfectant or preservative.
Patent NZ-571933-A (NZ)
Title: C-Met protein kinase inhibitors for the treatment of proliferative disorders
Inventor: LAUFFER DAVID J
IPC: A61K31/4439
Filed: 2007-03-21
Abstract: Disclosed is a heterocyclic compound of formula (I), or a salt thereof where the D ring is chosen from one of the five pictured rings, Z1 and Z2 are each either N or CR, Q is an optionally substituted phenyl ring, and the other substituents are as defined in the specification. Also disclosed is the use of a compound as a c-Met protein kinase inhibitor for treating proliferative disorders such as metastatic cancer, a glioblastoma, gastric carcinoma, atheresclerosis, or lung fibrosis.
Patent NZ-572178-A (NZ)
Title: Model systems and methods relating to zebrafish pro-apoptotic (zpa) polypeptides
Inventor: ASHKENAZI AVI J
IPC: C07K14/46
Filed: 2007-05-03
Abstract: Discloses a transgenic zebrafish containing amino-acid of SEQ ID No:1 and methods thereof to modulate or switch off expression of the SEQ ID No:1. Said methods provide a model system for determining activity of the intrinsic or extrinsic apoptotic pathways.
Patent NZ-572525-A (NZ)
Title: Detection method for influenza viruses
Inventor: BOVIN NIKOLAY VLADIMIROVICH
IPC: C12Q1/34
Filed: 2007-05-18
Abstract: Provided is a method of rapid detection of influenza viruses and/or virus particles comprising a hemagglutinin and a neuraminidase component, said method comprising the steps of: a) binding the viruses and/or virus particles to a support containing at least one type of carbohydrate receptor selected from the group consisting of natural or synthetic oligosaccharide, which is conjugated to, or situated in composition with glycoproteins which carbohydrate receptor binds to the hemagglutinin component of the viruses and/or virus particles; b) reacting the neuraminidase component of the bound viruses and/or virus particles with its labelled enzyme substrate, causing the generation of a detectable signal; and c) detecting the signal generated in step b).
Patent NZ-579989-A (NZ)
Title: 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
Inventor: CID-NUNEZ JOSE MARIA
IPC: A61P25/22
Filed: 2008-03-07
Abstract: Disclosed is a phenylene and cyano substituted pyridine-2-one of formula (I)wherein the substituents are as disclosed in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (I), the use of a compound of formula (I) in the manufacture of a medicament and the process for preparing a compound of formula (I). Examples of compounds are 1-Cyclopropylmethyl-4-[4-(2,3-dimethyl-pyridin-4-yloxy)-3-fluoro-phenyl] -2-oxo-1,2-dihydro-pyridine-3-carbonitrile and 3-cyano-1-butyl-4-[4-(2-methyl-pyridin-4-yloxy)-phenyl]-pyridine-2(1H)-one. Examples of diseases and conditions that the medicament can be used to treat are: central nervous system disorder selected from the group of anxiety disorders, psychotic disorders, personality disorders, substance-related disorders, eating disorders, mood disorders, migraine, epilepsy or convulsive disorders, childhood disorders, cognitive disorders, neurodegeneration, neurotoxicity and ischemia.
Patent NZ-591612-A (NZ)
Title: Prevention, treatment and diagnosis of p.gingivalis infection with peptides
Inventor: REYNOLDS ERIC CHARLES
IPC: A61K39/40
Filed: 2009-08-28
Abstract: Provided is a chimeric or fusion protein for inducing an immune response to P. gingivalis?the protein comprising a first peptide of about 5 to about 40 amino acids joined directly or through a linker to a second polypeptide?wherein: (A) said first peptide comprises a region of a P. gingivalis trypsin-like enzyme selected from the group consisting of: (i) part of, or all of a sequence that is the same as, or at least 90% identical to the sequence shown in SEQ ID No: 1; and as, or at least 90% identical to the sequence shown in SEQ ID No: 1; and (ii) part of, or all of a sequence that is the same as, or at least 90% identical to the sequence shown in SEQ ID No: 2; and (B) said second polypeptide comprises an adhesin domain of P. gingivalis or fragment thereof, selected from the group consisting of: (i) part of, or all of a sequence that is the same as, or at least 90% identical to the sequence of an adhesin domain of the Lys-X- proteinase of P. gingivalis; (ii) part of, or all of a sequence that is the same as, or at least 90% identical to the sequence of an adhesin domain of the Arg-Xproteinase of P. gingivalis; and (iii) part of, or all of a sequence that is the same as, or at least 90% identical to the sequence of a HagA adhesin domain of P. gingivalis, wherein said region or part of said trypsin-like enzyme and said fragment or part of said adhesin domain are capable of inducing an immune response against P. gingivalis.
Patent NZ-592283-A (NZ)
Title: Combination of an insulin and the GLP-1 agonist AVE0010
Inventor: WERNER ULRICH
IPC: A61K38/26
Filed: 2009-10-09
Abstract: A medicament, comprising a first pharmaceutical composition and a second pharmaceutical composition, and, optionally, at least one further pharmaceutical composition, which each comprise c) at least one insulin selected from unmodified insulins, insulin analogs, insulin derivatives and metabolites thereof each having insulin activity, and d) at least one GLP-1 receptor agonist, and contain the at least one insulin and/or the at least one GLP-1 receptor agonist in different weight fractions relative to the total weight of the composition, wherein the medicament is used to treat a patient with diabetes, more particularly type 1 or 2 diabetes, to adjust fasting, postprandial and/or postabsorptive blood glucose concentration, to improve glucose tolerance, to prevent hypoglycemia, or to promote weight loss and/or prevent weight gain, and wherein methods of treatment or prevention of diseases or conditions in humans are disclaimed.
Patent NZ-596479-A (NZ)
Title: N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
Inventor: ZHU WENYU
IPC: A61K31/519
Filed: 2010-05-21
Abstract: Disclosed is a compound of formula I, such as 3-[1-(6-chloropyrazin-2-yl)pyrrolidin-3-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile and 3-[1-(6-chloropyridin-2-yl)pyrrolidin-3-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, which is useful for modulating JAK1 and treating autoimmune, cancer and inflammatory diseases.
Patent NZ-596614-A (NZ)
Title: Diagnosis and treatment of alzheimer's disease
Inventor: WILLIAMS JULIE
IPC: A61P25/28
Filed: 2010-06-22
Abstract: Provided is a method for screening for, or diagnosing the likelihood of developing, or the existence of, Alzheimer's disease comprising testing a tissue sample for SNP rs3851179 in ICALM gene on chromosome 11, and optionally additionally testing for SNPs rs561655 or rs592297. Further provided and nucleotide sequences comprising the SNPs and cell lines expressing the SNP-bearing sequences.
Patent NZ-597466-A (NZ)
Title: Recombinant anti-epidermal growth factor receptor antibody compositions
Inventor: PEDERSEN MIKKEL WANDAHL
IPC: A61K39/395
Filed: 2008-02-27
Abstract: 597466 Disclosed is an anti-EGFR antibody or an antigen-binding fragment thereof, comprising the heavy chain CDR1, CDR2, and CDR2 amino acid sequences in SEQ ID NO: 50 and the light chain CDR1, CDR2, and CDR2 amino acid sequences in SEQ ID NO: 82 wherein SEQ ID NO: 50 is: RAEVQLVESGGGLVKPGESLKLSCAASGFAFSYSDMSWVRQTPEKRLEWVAYMSSAGDVTFYSDTVKGRFTISRDNAKNTLYLQVSSLKSEDTAIYYCVRHRDVAMDYWGQGTSVTVS and SEQ ID NO: 82 is: LADVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC.
Patent NZ-599701-A (NZ)
Title: Handle brake device
Inventor: VAN HOUTEM JOS
IPC: B60T7/10
Filed: 2010-10-01
Abstract: 599701 The invention concerns a handle brake device (10) suitable for being installed on a handlebar (11) of a wheelchair, a wheeled walker, a bicycle or the like. The handle brake device comprises a housing (1) fixedly mounted to the handlebar of the wheelchair, wheeled walker, bicycle or the like, a brake lever (2) rotatably installed in the housing, a transmission cable (3) connected to the brake lever via a cable connector (4). The brake lever (2) comprises a first arc hole (16) and a second arc hole (17), inside each of which a pivot pin (13', 13") fixedly connected to the housing is slideably engaged in such a manner as to provide dual pivot for the brake lever, respectively being a first pivot (A) and a second pivot (B). Each arc hole has a lower end (16', 17') and a higher end (see 16" & 17", figure 5). When the lever is pulled by the user toward the handlebar the brake lever rotates firstly around the first pivot when said first pivot is positioned at the lower end (16') of the first arc hole and the second pivot is positioned at the higher end of the second arc hole. Secondly, the brake lever rotates around the second pivot when the first pivot is positioned at the lower end of the first arc hole and the second pivot is positioned at the lower end of the second arc hole. The handle brake device allows the user to apply a constant braking force throughout the movement of the brake lever, as opposed to conventional single pivot handle brake devices where the user must apply a progressively increasing braking force throughout movement of the brake lever.
Patent NZ-600110-A (NZ)
Title: Process for the preparation of compounds useful as inhibitors of sglt
Inventor: ABDEL-MAGID AHMED F
IPC: A61P3/00
Filed: 2008-09-09
Abstract: 600110 Disclosed is a process for preparing a compound of formula (I) comprising reacting a compound of formula (V) with a compound of formula (VI-S), in the presence of an alkyl lithium, wherein the alkyl lithium is selected from the group consisting of trimethylsilylmethyl lithium, 2,4,6-trimethylphenyllithium and triethylsilylmethyl lithium; in an organic solvent, at a temperature in the range of from about O DEGREE C to about -78 DEGREE C; to yield the corresponding compound of formula (VII); and wherein the alkyl lithium is added to a mixture of the compound of formula (V) and the compound of formula (VI-S); reacting the compound of formula (VII) with BF30Et2, in the presence of a trialkylsilane, in an organic solvent, to yield the corresponding compound of formula (VIII); reacting the compound of formula (VIII) with acetic anhydride or acetyl chloride, in the presence of an organic base, neat or in an organic solvent, to yield the corresponding compound of formula (IX); and de-protecting the compound of formula (IX), to yield the corresponding compound of formula (I).
Patent NZ-602862-A (NZ)
Title: Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Inventor: HONG QI
IPC: A61K31/485
Filed: 2005-03-30
Abstract: 602862 Disclosed is a process for reducing the amount of 14-hydroxycodeinone in an oxycodone hydrochloride composition to less than 25 ppm, which process comprises the step of hydrogenating the oxycodone hydrochloride composition. Preferably the process is performed with a palladium on carbon catalyst in the presence of acid. Also disclosed is the compound 8a,14-Dihydroxy-7,8-dihydrocodeinone.
Patent NZ-604029-A (NZ)
Title: Methods of treating bladder cancer
Inventor: SOON-SHIONG PATRICK
IPC: A61P35/04
Filed: 2011-05-20
Abstract: Disclosed is a method of treating bladder cancer in an individual in need thereof, comprising administering to the individual an effective amount of a composition comprising nanoparticles comprising a taxane and an albumin. Also disclosed is (a) a composition comprising nanoparticles comprising a taxane and albumin; (b) a platinum-based agent; and (c) of an antimetabolite for use in treating bladder cancer. Further disclosed is a composition comprising nanoparticles comprising a taxane and an albumin in the manufacture of a medicament to treat non-muscle-invasive bladder cancer in an individual in need thereof, wherein the medicament is in a form for intravesicular administration, wherein the medicament is in a form for administration at the dose of about 100 mg to about 600 mg.
Patent NZ-614432-A (NZ)
Title: Derivatives of azaindazole or diazaindazole type as medicament
Inventor: KALOUN EL BACHIR
IPC: C07D471/04
Filed: 2012-01-27
Abstract: The disclosure relates to an azaindazole or diazaindazole derivative compound of formula (I), a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same. These compounds are intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer’s disease.
Patent NZ-618391-A (NZ)
Title: Antigenic tau peptides and uses thereof
Inventor: ZHU JEFF XIANCHAO
IPC: C07K14/47
Filed: 2010-07-20
Abstract: Disclosed is an immunogen comprising an antigenic tau peptide linked to an immunogenic carrier, wherein the antigenic tau peptide comprises a pThr-231/pSer-235 phospho-tau epitope and consists of an amino acid sequence selected from SEQ ID NOs: 16, 17 and 18. >16 VVRTPPKSP >17 RTPPKSPSS >18 RTPPKSP
Patent NZ-629182-A (NZ)
Title: Antimicrobial elastomeric articles
Inventor: KROGMAN NICHOLAS
IPC: C08J7/056
Filed: 2013-02-14
Abstract: Provided are methods for preparing antimicrobial elastomeric articles comprising the exposure of the articles to reduced humidity environments. In one embodiment the method comprises the following steps: coating an elastomeric article heated to 55°C ± 5°C with an antimicrobial coating composition to form an antimicrobial elastomeric article; exposing the antimicrobial elastomeric article to an environment comprising about 10.3 g/m3 or less absolute humidity; and packaging the antimicrobial elastomeric article in a packaging system; wherein the antimicrobial elastomeric article, when aged in the packaging system for 7 days at 70°C, has an antimicrobial efficacy such that the number of microorganisms present on a surface of the antimicrobial elastomeric article is reduced by at least 4 log10 within 5 minutes, wherein the steps of coating and exposing may be reversed. Examples of the antimicrobial elastomeric articles include gloves, condoms, probe covers and catheters. A preferred antimicrobial coating composition comprises the antimicrobial agent chlorhexidine gluconate.
Patent NZ-630201-A (NZ)
Title: An exercise device
Inventor: CONEN ALLAN
IPC: A63B21/06
Filed: 2013-04-03
Abstract: An exercise device (10) comprising a hollow body (12) comprising a flexible wall, and at least one handle. The body comprises a tubular mid-portion and hemispherical end portions defining a cavity. The cavity can be substantially emptied to configure the body (12) into a collapsed configuration and the cavity can be substantially filled to configure the body (12) into an expanded configuration. The at least one handle (20) has first and second mounting means (25a, 25b) and a grip therebetween, wherein the first and second mounting means (25a, 25b) are fixedly attached to the body (12). The body comprises a valve assembly which allows filling with a liquid, gas and/or solid and can provide weight to the exercise device.